School of Medicine
Showing 61-80 of 259 Results
-
An Ni Zhang
Postdoctoral Scholar, Stanford Cancer Institute
BioAnni obtained her Ph.D. in Dr. James Johnson and Dr. Janel Kopp's labs at the University of British Columbia. Her Ph.D. work showed that hyperinsulinemia contributes to pancreatic cancer development. Her work also showed that insulin directly acted via the insulin receptors in pancreatic acinar cells to increase digestive enzyme production, thereby generating an inflammatory condition that accelerates neoplastic transformation. She is now working at Diehn lab to investigate the mechanisms of KEAP1 mutation-induced immunotherapy resistance in lung cancer.
-
Bing Melody Zhang
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main research interests lie in the following areas:
1) HLA testing for BMT/solid organ transplantation
2) NGS-based TCR/Ig clonality/MRD testing
3) HLA testing in cellular therapy and oncology
4) Genetic/genomic testing for malignant and non-malignant hematologic disorders
5) HLA-related disease association/drug hypersensitivity testing. -
Caixiang Zhang
Affiliate, Urology - Divisions
Visiting Scholar, Urology - DivisionsBioHe is a medical doctor and attending physician. Since October 2025, he has been a visiting scholar at Stanford Health Care. He graduated from Capital Medical University. Since 2019, he has been working at Capital Medical University Beijing Friendship Hospital, and has been engaged in the front-line clinical work of urology for a long time. He is dedicated to the diagnosis and treatment of prostate diseases and urological tumors. His main research focuses on clinical and basic research, and he has published many papers in SCI and Chinese core journals, as well as one patent.
-
Chongyang Zhang
Postdoctoral Scholar, Cardiology
BioDr. Zhang is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. She has a PhD in Pharmacology from University of Rochester, NY. She has research in cardiovascular research and chronobiology published in high impact peer-reviewed journals. She is recipient of honors including predoctoral fellowship from AHA, Travel Grant for Early Career Investigators from Council on Arteriosclerosis, Thrombosis, and Vascular Biology. She has served as ad hoc reviewer for more than 40 manuscripts for reputed journals.
-
Fanglin Zhang, MD., PhD.
Clinical Associate Professor, Adult Neurology
BioDr. Zhang is a Clinical Associate Professor of Neurology and Neurological Sciences at Stanford University, where she is dedicated to diagnosing and treating complex neurological disorders in both inpatient and outpatient settings. She is a board-certified, fellowship-trained neurologist and clinical neurophysiologist. Dr. Zhang prioritizes building strong partnerships with her patients, focusing on overcoming neurological diseases and enhancing their quality of life through patient-centered and evidence-based medicine. Her approach emphasizes collaboration and communication, ensuring that her patients are actively involved in their care and treatment plans.
As a clinician educator, Dr. Zhang takes great pleasure in mentoring trainees. She serves as the site director for both the Stanford Neurology Residency Program and the Neurohospitalist Fellowship Program. Additionally, she is the Education Director at Stanford Health Care Tri-Valley Neurology.
Dr. Zhang is passionate about conducting innovative clinical research, with her findings published in numerous peer-reviewed journals. She is also deeply committed to community service and global health, dedicating her time and expertise to initiatives that aim to improve health outcomes and access to care for diverse populations. -
Hao Zhang
Instructor, Cardiovascular Institute
BioI earned my M.D. from Peking Union Medical College, Tsinghua University. Subsequently, I completed my residency and served as a cardiac fellow at Fuwai Hospital, where I developed a strong foundation in the pathophysiology of cardiovascular diseases.
As a postdoctoral researcher and instructor in Dr. Joseph Wu’s lab at Stanford, I established a protocol to derive cardiac fibroblasts (CFs) from human iPSCs, providing an unlimited source of cells for studying cardiac fibrosis. This method generates homogenous iPSC-derived CFs that remain quiescent yet responsive to profibrotic stimuli. Notably, this protocol played a crucial role in developing a multiscale drug discovery platform that integrates human iPSCs, 3D-engineered heart tissues, and animal models of heart failure. Using this platform, I discovered novel signaling pathways and therapeutic targets for cardiac fibrosis. My most recent work has been published in Cell (https://doi.org/10.1016/j.cell.2024.09.034).
